Jounce Therapeutics Inc
JNCE · Chemicals & Drugs · NASDAQ · in our data January 27, 2017 to May 3, 2023 (6.3 years)
The first trading day in our data for Jounce Therapeutics Inc is January 27, 2017 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on March 14, 2018, the market valued it at $920 million. It ended in a collapse: the last trade was $1.88, -93.4% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2017.
Play today's Daily DropAlso gone in 2023: Chemicals & Drugs
- Seagen Inc peaked at $43.2 billion
- Intercept Pharma Inc peaked at $9.0 billion
- Reata Pharmaceuticals Inc peaked at $6.9 billion
- Amyris Inc peaked at $6.0 billion
- Iveric Bio Inc peaked at $5.5 billion
- Sorrento Therapeutics Inc peaked at $4.6 billion
